Trial · NCT07896473
Study Comparing Osteoarthritis Programs
NCT07896473, Not applicable, Not yet recruiting, Weill Medical College of Cornell University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study Comparing Osteoarthritis Programs. Trials, record NCT07896473. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896473
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study Comparing Osteoarthritis Programs
- NCT number
- NCT07896473
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Weill Medical College of Cornell University
- Conditions
- Osteoarthritis
- Interventions
- I'm Walking, Walk With Ease
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference between groups in pain interference as measured by PROMIS Pain Interference (PI) Short Form 8a at week 24 | Week 24 | Pain interference will be measured by the 8-item PROMIS Short Form 8a Pain Interference measure. This measure assesses how much pain disrupts a person's daily activities and enjoyment of life over the past 7 days. Each question is a 5-point likert scale from 1 (Not at all) to 5 (Very much) with a higher score indicating more pain interference. In the general population, T-scores have a mean of 50, standard deviation of 10, and range from 40.7 to 77.0. Lower T-scores represent better outcomes. |
| Secondary | Difference between groups in pain intensity (Brief Pain Inventory Pain Intensity Subscale) at Week 24 | Week 24 | Patient-reported pain intensity will be measured by the 4-item Brief Pain Inventory Pain Intensity Subscale. This assess the severity of pain and impact on mood, walking, and other daily activities. Each question is an 11-point numeric reading scale from 0 (no pain) to 10 (pain as bad as you can imagine), the overall score range is 0 to 40 with a higher score indicating higher pain intensity. |
| Secondary | Difference between groups in physical function (PROMIS Physical Function Short Form 6b) at week 24 | Week 24 | Patient-reported difficulty with activities of daily living as measured by the 6-item PROMIS Physical Functioning Short Form 6b. This measures a person's ability to perform activities such as chores, activities of daily living, and climbing stairs. Each question is a five-point likert scale from 5 (without any difficulty) to 1 (unable to do) with a lower score indicating lower physical function. In the general population, T-scores have a mean of 50, standard deviation of 10, and range from 21.0 to 59.0. Higher T-scores represent better outcomes. |
| Secondary | Difference between groups in depressive symptoms (Patient Health Questionnaire; PHQ-8) at week 24 | Week 24 | Depressive Symptoms will be measured by PHQ-8 (Patient Health Questionnaire). This 8-item instruments measures symptoms of depression over the past 2 weeks such as, 'feeling down, depressed, or hopeless' or 'poor appetite or overeating'. Respondents report level of depression symptoms on a 4-point scale from 0 (Not at all) to 3 (Nearly every day). The overall score range is 0 to 24 with a higher score indicating higher depressive symptoms. |
| Secondary | Difference between groups in anxiety symptoms (Generalized Anxiety Disorder; GAD-7) at week 24 | Week 24 | Anxiety Symptoms will be measured by GAD-7 (Generalized Anxiety Disorder-7). This 7-item instruments measures symptoms of anxiety over the past 2 weeks such as, 'feeling nervous, anxious, or on edge', 'trouble relaxing'. Respondents report level of anxiety symptoms on a 4-point scale from 0 (Not at all) to 3 (Nearly every day). The overall score range is 0 to 21 with a higher score indicating higher anxiety symptoms. |
| Secondary | Difference between groups in treatment satisfaction (Patient Global Impression of Change; PGIC) at week 24 | Week 24 | Patient-reported global impression of change as measured by 1-item PGIC scale. This assesses the patient's overall perception of improvement or worsening of their symptoms since the start of the study on a 7-point likert scale from very much improved (1) to very much worse (7) with a higher score indicating greater perceived improvement. |
| Secondary | Difference between groups in knee pain (Knee Injury and Osteoarthritis Outcome Score, KOOS pain subscale) at week 24 | Week 24 | Knee pain will be measured by KOOS pain subscale consisting of 9-items. Each question is a 5-point likert score from 0 (no problems) to 5 (extreme problems). Scores are then calculated to a scale of 0-100 with a higher score indicating better pain. |
| Secondary | Difference between groups in knee function (Knee Injury and Osteoarthritis Outcome Score, KOOS function subscale) at week 24 | Week 24 | Knee function will be measured by KOOS function in daily living (ADL) subscale consisting of 17-items. Each question is a 5-point likert score from 0 (no problems) to 5 (extreme problems). Scores are then calculated to a scale of 0-100 with a higher score indicating better function. |
| Secondary | Difference between groups in sleep disturbance (PROMIS Sleep Disturbance Short Form 6a) at Week 24 | Study week 24 | Patient-reported sleep disturbance as measured by the 6-item PROMIS Sleep Disturbance Short Form 6a. This measures a person's sleep disturbance such as quality, difficulty falling asleep, restless. Each question is a five-point likert scale from 5 (very poor or not at all) to 1 (very good or very much) with a lower score indicating lower sleep disturbance (2 reverse scored questions). In the general population, T-scores have a mean of 50, standard deviation of 10, and range from 31.7 to 76.1. Higher T-scores represent better sleep disturbance outcomes. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| P30AG022845 | Cornell Roybal Center-Translational Research Institute on Pain in Later Life | REID, MANNEY CARRINGTON; WETHINGTON, ELAINE | WEILL MEDICAL COLL OF CORNELL UNIV | NATIONAL INSTITUTE ON AGING | 2003 to 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07896473
GET https://conductscience.org/api/trials/v1/NCT07896473/registered